Santi Enrico, Cerretti Raffaella, De Angelis Gottardo, Mariotti Benedetta, Ciangola Giulia, Page Camilla, Rossi Elisa Lindfors, Pasqualone Gianmario, A. William
{"title":"Allogeneic hematopoietic cell transplantation to treat two synchronous hematologic malignancies","authors":"Santi Enrico, Cerretti Raffaella, De Angelis Gottardo, Mariotti Benedetta, Ciangola Giulia, Page Camilla, Rossi Elisa Lindfors, Pasqualone Gianmario, A. William","doi":"10.29328/journal.jsctt.1001025","DOIUrl":null,"url":null,"abstract":"Allogeneic hematopoietic cell transplantation often represents the only solution for several poor-prognosis hematologic malignancies. The curative strategy for patients with synchronous hematologic disorders is always difficult and, in most cases, ineffective. Herein, we report an unusual case of synchronous hematologic disorders successfully treated with an “ad-hoc” conditioning regimen followed by allogeneic hematopoietic cell transplantation.","PeriodicalId":92683,"journal":{"name":"Journal of stem cell therapy and transplantation","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stem cell therapy and transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29328/journal.jsctt.1001025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Allogeneic hematopoietic cell transplantation often represents the only solution for several poor-prognosis hematologic malignancies. The curative strategy for patients with synchronous hematologic disorders is always difficult and, in most cases, ineffective. Herein, we report an unusual case of synchronous hematologic disorders successfully treated with an “ad-hoc” conditioning regimen followed by allogeneic hematopoietic cell transplantation.